Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PTT-936 by Pyrotech Therapeutics for Solid Tumor: Likelihood of Approval
PTT-936 is under clinical development by Pyrotech Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...